Keywords
Hepatitis B ×
Eligibility Determination ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

87 Search results.

Eligibility Hepatitis B NCT01463683

- 5/31/20 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062); ODM derived from: https://clinicaltrials.gov/show/NCT01463683

Eligibility Hepatitis B NCT01333813

- 5/30/20 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children; ODM derived from: https://clinicaltrials.gov/show/NCT01333813

Eligibility Hepatitis B Chronic Infection NCT01745822

- 5/29/20 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand; ODM derived from: https://clinicaltrials.gov/show/NCT01745822

Eligibility Hepatitis NCT01724723

- 2/16/20 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT01724723

Eligibility Hepatitis B, Chronic NCT02498275

- 1/30/20 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Effect of RO6871765 and RO7011785 on Immune Response With the Stimulation of Peripheral Blood Mononuclear Cells (PBMCs) in Chinese Healthy Volunteers and Chronic Hepatitis B Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02498275

Eligibility Hepatitis B, Chronic NCT02366208

- 1/30/20 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B; ODM derived from: https://clinicaltrials.gov/show/NCT02366208

Eligibility Hepatitis B, Chronic NCT02366247

- 1/30/20 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B; ODM derived from: https://clinicaltrials.gov/show/NCT02366247

Eligibility Hepatitis B, Chronic NCT02097004

- 1/29/20 - 1 form, 2 itemgroups, 31 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection; ODM derived from: https://clinicaltrials.gov/show/NCT02097004

Eligibility Hepatitis B, Chronic NCT01886300

- 1/29/20 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive Chronic Hepatitis B in Vietnam; ODM derived from: https://clinicaltrials.gov/show/NCT01886300

Eligibility Hepatitis B, Chronic NCT02167113

- 1/29/20 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay; ODM derived from: https://clinicaltrials.gov/show/NCT02167113

Eligibility Hepatitis B, Chronic NCT01794234

- 1/29/20 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues; ODM derived from: https://clinicaltrials.gov/show/NCT01794234

Eligibility Hepatitis B, Chronic NCT01519960

- 1/29/20 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B; ODM derived from: https://clinicaltrials.gov/show/NCT01519960